|Alma mater||Stanford University
University of California, Berkeley
|Occupation||Former CEO of Novartis|
Jimenez began his career at Clorox before joining ConAgra Foods.[non-primary source needed] Prior to joining Novartis, he was head of H. J. Heinz Company's North American business from 2002 to 2006. He was also a non-executive director of AstraZeneca from 2002 to 2007, as well as an advisor for the Blackstone Group.
During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis' operations. His cost-cutting moves, focused mostly on marketing and administration, came steadily, with more than a billion cut in 2010, and even more than that in 2011.
Role In Influence Peddling Scandal
Jimenez paid Michael Cohen (President Trump's lawyer) $1.2 million USD, possibly for communications or favors with President Trump. Jimenez told Forbes Magazine that he brought Cohen into the company and approved the contract without knowing who Cohen was, except that he was connected to Trump and the Trump Organization.
- "Fix the Problem, and Not Just the Symptoms". New York Times. Retrieved 22 May 2013.
- "Joseph Jimenez MBA". Businessweek. Retrieved 22 May 2013.
- "Joseph Jimenez - Forbes". People.forbes.com. 2012-04-18. Retrieved 2012-08-02.
- "Joseph Jimenez - The 25 most influential people in biopharma today". Fierce Biotech. Retrieved 22 May 2013.
- Greil, Anita (2010-01-26). "Vasella's Impeccable Timing - The Source - WSJ". Blogs.wsj.com. Retrieved 2012-08-02.
- "Novartis CEO Jimenez to Quit, Giving Reins to Harvard Doctor". Bloomberg.com. Bloomberg Technology. 4 September 2017. Retrieved 5 September 2017.